CIK 0001314102 · Non-accelerated filer<br>Smaller reporting company
EyePoint, Inc.
Sign in to watch- Ticker
- EYPT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262774444
- Phone
- 617-926-5000
- Business address
- 480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
- Former names
- EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
- Open-market buys, last 90 days
- $52,258
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$52,258. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-20 | Elston George Chief Financial Officer | Other disposition | −5,000 | 25,000 | ||
| 2026-08-20 | Elston George Chief Financial Officer | Other acquisition | +5,000 | 96,691 | ||
| 2026-08-20 | Elston George Chief Financial Officer | Gift | −64,953 | 32,517 | ||
| 2026-08-20 | Elston George Chief Financial Officer | Gift | +64,953 | 64,953 | ||
| 2026-08-18 | Zaderej Karen L. Director | Purchase | +10,600 | $4.93 | $52K | 49,100 |
| 2026-07-10 | Duker Jay S. President and CEO | Option exercise | +16,667 | 17,653 | ||
| 2026-07-10 | Duker Jay S. President and CEO | Shares withheld for taxes | −8,059 | $14.72 | $119K | 9,594 |
| 2026-07-10 | Duker Jay S. President and CEO | Option exercise · Restricted Stock Units | −16,667 | 0 | ||
| 2026-06-30 | Ribeiro Ramiro Chief Medical Officer | Option exercise 10b5-1 | +2,437 | $8.26 | $20K | 2,437 |
| 2026-06-30 | Ribeiro Ramiro Chief Medical Officer | Option exercise 10b5-1 | +2,438 | $8.26 | $20K | 4,875 |
| 2026-06-30 | Ribeiro Ramiro Chief Medical Officer | Sale 10b5-1 | −2,437 | $15.00 | $37K | 2,438 |
| 2026-06-30 | Ribeiro Ramiro Chief Medical Officer | Sale 10b5-1 | −2,438 | $15.02 | $37K | 0 |
| 2026-06-30 | Ribeiro Ramiro Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,437 | 78,001 | ||
| 2026-06-30 | Ribeiro Ramiro Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,438 | 75,563 | ||
| 2026-05-25 | Elston George Chief Financial Officer | Option exercise | +7,500 | 95,318 | ||
| 2026-05-25 | Elston George Chief Financial Officer | Shares withheld for taxes | −3,627 | $12.93 | $47K | 91,691 |
| 2026-05-25 | Elston George Chief Financial Officer | Option exercise · Restricted Stock Units | −7,500 | 0 | ||
| 2026-04-17 | Ribeiro Ramiro Chief Medical Officer | Option exercise 10b5-1 | +2,437 | $8.26 | $20K | 2,437 |
| 2026-04-17 | Ribeiro Ramiro Chief Medical Officer | Sale 10b5-1 | −2,437 | $15.00 | $37K | 0 |
| 2026-04-17 | Ribeiro Ramiro Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,437 | 80,438 |
Page 1 of 18 · 352 trades